Company profile: Procemsa
1.1 - Company Overview
Company description
- Provider of development, production and packaging services for food supplements, medical devices and cosmetics, supported by state-of-the-art production facilities and a Research and Development Center, offering regulatory support, clinical trial services and stability studies.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Procemsa
Pinteon Therapeutics
HQ: United States
Website
- Description: Provider of a monoclonal antibody therapeutic, PNT001, targeting cis-pT231 tau to reduce neurodegeneration and cognitive impairment in traumatic brain injury, chronic traumatic encephalopathy, Alzheimer's disease, and progressive supranuclear palsy; advancing clinical studies of this novel antibody.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Pinteon Therapeutics company profile →
Roquefort Therapeutics
HQ: United Kingdom
Website
- Description: Provider of pre-clinical anti-cancer therapeutics, including Midkine-targeting antibodies; antisense oligonucleotides to reduce Midkine in cancer cells; gene-editing RNA and mRNA therapies for solid tumors; STAT-6 siRNA therapeutics; and MK cell therapy with direct and NK cell-mediated action, advancing candidates toward clinical trials.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Roquefort Therapeutics company profile →
Santarus
HQ: United States
Website
- Description: Provider of specialty biopharmaceutical products focused on acquiring, developing and commercializing proprietary therapies that address the needs of patients treated by physician specialists; current commercial efforts encompass five products, including UCERIS (budesonide) extended release tablets.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Santarus company profile →
Valera Pharmaceuticals
HQ: United States
Website
- Description: Provider of specialty pharmaceutical services concentrating on development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Valera Pharmaceuticals company profile →
Cephalon
HQ: United States
Website
- Description: Provider of biopharmaceutical discovery, development, and commercialization of medications to improve quality of life worldwide. Founded in 1987, the company delivers first-in-class and best-in-class medicines across several therapeutic areas.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cephalon company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Procemsa
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Procemsa
2.2 - Growth funds investing in similar companies to Procemsa
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Procemsa
4.2 - Public trading comparable groups for Procemsa
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →